Association between long interspersed nuclear element-1 methylation levels and relapse in Wilms tumors

[1]  K. Burns,et al.  The Human Long Interspersed Element-1 Retrotransposon: An Emerging Biomarker of Neoplasia. , 2017, Clinical chemistry.

[2]  P. Pearson,et al.  DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations , 2016, Oncotarget.

[3]  C. Rübe,et al.  Paediatric renal tumours: perspectives from the SIOP–RTSG , 2017, Nature Reviews Urology.

[4]  M. V. Van Noord,et al.  Biomarkers for Wilms Tumor: A Systematic Review. , 2016, The Journal of urology.

[5]  James R. Anderson,et al.  Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Dong,et al.  Genome-wide analysis of DNA methylation in hepatoblastoma tissues. , 2016, Oncology letters.

[7]  M. O'sullivan,et al.  Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Ellison,et al.  DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas , 2016, Acta Neuropathologica Communications.

[9]  H. Kazazian,et al.  Roles for retrotransposon insertions in human disease , 2016, Mobile DNA.

[10]  H. Brentani,et al.  DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations. , 2016, Oncotarget.

[11]  Yuan-yuan Li,et al.  Association between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms Tumor , 2015, Chinese medical journal.

[12]  K. Pritchard-Jones,et al.  Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial , 2015, The Lancet.

[13]  K. Pritchard-Jones,et al.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Pritchard-Jones,et al.  Biomarkers to detect Wilms tumors in pediatric patients: where are we now? , 2015, Future oncology.

[15]  Kristopher L. Nazor,et al.  DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights. , 2015, Epigenomics.

[16]  J. Martín-Subero,et al.  DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights , 2015, Genomics data.

[17]  S. Beck,et al.  Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour , 2015, Genome Medicine.

[18]  H. Baba,et al.  LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas , 2015, Annals of Surgical Oncology.

[19]  M. Vinciguerra,et al.  LINE-1 Hypomethylation in Blood and Tissue Samples as an Epigenetic Marker for Cancer Risk: A Systematic Review and Meta-Analysis , 2014, PloS one.

[20]  Wei Zhu,et al.  The Prognostic Value of Global DNA Hypomethylation in Cancer: A Meta-Analysis , 2014, PloS one.

[21]  S. Beck,et al.  Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood , 2014, Genome Biology.

[22]  Andrew Menzies,et al.  Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes , 2014, Science.

[23]  Volker Hovestadt,et al.  Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays , 2013, Acta Neuropathologica.

[24]  Euan J. Rodger,et al.  Global demethylation in loss of imprinting subtype of wilms tumor , 2013, Genes, chromosomes & cancer.

[25]  H. Baba,et al.  LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis , 2012, Gastric Cancer.

[26]  C. Larsson,et al.  Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas , 2012, BMC Medical Genetics.

[27]  Nazneen Rahman,et al.  Stratification of Wilms tumor by genetic and epigenetic analysis , 2012, Oncotarget.

[28]  K. Pritchard-Jones,et al.  Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract] , 2011 .

[29]  James R. Anderson,et al.  WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  B. de Camargo,et al.  Socioeconomic status and the incidence of non-central nervous system childhood embryonic tumours in Brazil , 2011, BMC Cancer.

[31]  J. Dome,et al.  Treatment of relapsed Wilms tumors: lessons learned , 2009, Expert review of anticancer therapy.

[32]  Norman Breslow,et al.  Subsets of Very Low Risk Wilms Tumor Show Distinctive Gene Expression, Histologic, and Clinical Features , 2009, Clinical Cancer Research.

[33]  G. Vujanić,et al.  The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach , 2009, Journal of Clinical Pathology.

[34]  Paolo Boffetta,et al.  Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. , 2009, Cancer research.

[35]  Shuji Ogino,et al.  A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. , 2008, Journal of the National Cancer Institute.

[36]  Eva Steliarova-Foucher,et al.  Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[37]  W. Schulz.  L1 Retrotransposons in Human Cancers , 2006, Journal of biomedicine & biotechnology.

[38]  P. Laird,et al.  Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.

[39]  Giovanni Parmigiani,et al.  Human L1 Retrotransposition Is Associated with Genetic Instability In Vivo , 2002, Cell.

[40]  Dieter Harms,et al.  Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. , 2002, Medical and pediatric oncology.

[41]  P. Voûte,et al.  Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. , 2001, Annals of Oncology.